Literature DB >> 16900392

Benign breast diseases.

Carine Courtillot1, Geneviève Plu-Bureau, Nadine Binart, Corinne Balleyguier, Brigitte Sigal-Zafrani, Vincent Goffin, Frédérique Kuttenn, Paul A Kelly, Philippe Touraine.   

Abstract

Benign breast diseases have always been neglected in comparison to cancer, despite the fact that there are many more patients with such diseases than patients presenting to a breast clinic for cancer. Like normal breast tissues, benign breast diseases are under a complex system of controls by both systemic hormonal and local factors. In this review, we attempt to present an overview of the latest knowledge concerning the epidemiology, classification, clinical presentation, management, and physiopathology of these disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16900392     DOI: 10.1007/s10911-006-9006-4

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  46 in total

1.  Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues.

Authors:  P Touraine; J F Martini; B Zafrani; J C Durand; F Labaille; C Malet; A Nicolas; C Trivin; M C Postel-Vinay; F Kuttenn; P A Kelly
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

Review 2.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma.

Authors:  J R Pasqualini; J Cortes-Prieto; G Chetrite; M Talbi; A Ruiz
Journal:  Int J Cancer       Date:  1997-03-17       Impact factor: 7.396

Review 4.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

5.  Multiple forms of TGF-beta 1 in breast tissues: a biologically active form of the small latent complex of TGF-beta 1.

Authors:  R Baillie; R C Coombes; J Smith
Journal:  Eur J Cancer       Date:  1996-08       Impact factor: 9.162

6.  Long-term risk of breast cancer in women with fibroadenoma.

Authors:  W D Dupont; D L Page; F F Parl; C L Vnencak-Jones; W D Plummer; M S Rados; P A Schuyler
Journal:  N Engl J Med       Date:  1994-07-07       Impact factor: 91.245

7.  Hepatocyte growth factor/scatter factor expression in human mammary epithelium.

Authors:  Y Wang; A C Selden; N Morgan; G W Stamp; H J Hodgson
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  Fibroadenoma of the breast: sonomammography correlated with pathology in 122 patients.

Authors:  C Cole-Beuglet; R Z Soriano; A B Kurtz; B B Goldberg
Journal:  AJR Am J Roentgenol       Date:  1983-02       Impact factor: 3.959

9.  Prediction of response to endocrine therapy in pronounced cyclical mastalgia using dynamic tests of prolactin release.

Authors:  S Kumar; R E Mansel; L E Hughes; C A Edwards; M F Scanlon
Journal:  Clin Endocrinol (Oxf)       Date:  1985-12       Impact factor: 3.478

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  14 in total

1.  Effectiveness of Centchroman on Regression of Fibroadenosis and Mastalgia.

Authors:  Udayakumar Rajswaroob; Rajendiran Kannan; Narayanasamy Subbaraju Kannan; T Tirouaroul
Journal:  J Clin Diagn Res       Date:  2016-10-01

2.  Minimally Invasive Breast Fibroadenoma Excision Using an Ultrasound-Guided Vacuum-Assisted Biopsy Device.

Authors:  Thomas Papathemelis; Stefanie Heim; Michael P Lux; Ines Erhardt; Anton Scharl; Sophia Scharl
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-02       Impact factor: 2.915

3.  History of benign breast disease and risk of breast cancer among women in China: a case-control study.

Authors:  Tsogzolmaa Dorjgochoo; Sandra L Deming; Yu-Tang Gao; Wei Lu; Ying Zheng; Zhixian Ruan; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2008-03-18       Impact factor: 2.506

4.  Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland.

Authors:  J M Faupel-Badger; M E Sherman; M Garcia-Closas; M M Gaudet; R T Falk; A Andaya; R M Pfeiffer; X R Yang; J Lissowska; L A Brinton; B Peplonska; B K Vonderhaar; J D Figueroa
Journal:  Br J Cancer       Date:  2010-08-24       Impact factor: 7.640

Review 5.  Promoter methylation and the detection of breast cancer.

Authors:  Jennifer Brooks; Paul Cairns; Anne Zeleniuch-Jacquotte
Journal:  Cancer Causes Control       Date:  2009-11       Impact factor: 2.506

6.  Progesterone receptors A and B and estrogen receptor alpha expression in normal breast tissue and fibroadenomas.

Authors:  Gisele Branchini; Lolita Schneider; Rodrigo Cericatto; Edison Capp; Ilma Simoni Brum
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

7.  Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.

Authors:  Roman L Bogorad; Carine Courtillot; Chidi Mestayer; Sophie Bernichtein; Lilya Harutyunyan; Jean-Baptiste Jomain; Anne Bachelot; Frédérique Kuttenn; Paul A Kelly; Vincent Goffin; Philippe Touraine
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

8.  Profile of Breast Diseases in Post Pubertal Women Assessed By Clinical Breast Examination - A Community Based Study in Rural Pondicherry.

Authors:  Kavasseri L Janaki; Narayanasamy Subbaraju Kannan; M Palaniappan; Partha Nandi
Journal:  J Clin Diagn Res       Date:  2016-02-01

9.  Gene and protein expression of p53 and p21 in fibroadenomas and adjacent normal mammary tissue.

Authors:  Lolita Schneider; Gisele Branchini; Rodrigo Cericatto; Edison Capp; Ilma Simoni Brum
Journal:  Endocrine       Date:  2008-11-11       Impact factor: 3.633

10.  Differential expression of follistatin and FLRG in human breast proliferative disorders.

Authors:  Enrrico Bloise; Henrique L Couto; Lauretta Massai; Pasquapina Ciarmela; Marzia Mencarelli; Lavinia E Borges; Michela Muscettola; Giovanni Grasso; Vania F Amaral; Geovanni D Cassali; Felice Petraglia; Fernando M Reis
Journal:  BMC Cancer       Date:  2009-09-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.